IMCR - CIK 0001671927
Immunocore Holdings plc (IMCR) reported net income of -$35.51M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$35.51M | +30.5% |
| FY 2024 | -$51.09M | +7.6% |
| FY 2023 | -$55.29M | -5.2% |
| FY 2022 | -$52.54M | +70.8% |
| FY 2021 | -$180.03M | - |
Immunocore Holdings plc (IMCR) reported net income of -$35.51M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2021 and fiscal 2025, Immunocore Holdings plc's net income grew from -$180.03M to -$35.51M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.